This Cancer Research Catalyst blog reports on the release of the sixth annual AACR Cancer Progress Report, which highlights how federally funded research powers progress against cancer.
AACR Presents E-cigarette Webinar to Educate the Public
Combining Cytokine-based Immunotherapy AM0010 with Pembrolizumab Yielded Durable Responses in Patients with Advanced Solid Tumors
Ratio of Certain Immune Cells to Tumor Burden Correlated With Outcome For Pembrolizumab-treated Patients With Melanoma
Health Navigation Assistance Added to Community Helpline Connected More People to Cancer Control Measures
Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, Sept. 25-28, 2016
AACR Conference on The Science of Cancer Health Disparities, Sept. 25-28, 2016
San Antonio Breast Cancer Symposium, Dec. 6-10, 2016
AACR Annual Meeting 2017, April 1-5, 2017
In a blog posted on medium.com, experts from the American Association for Cancer Research and Cancer Research Institute share their thoughts about the research discussed at the conference, and the challenges and future of cancer immunotherapy.
HealthDay reported on this important study presented at the Conference on The Science of Cancer Health Disparities underway in Fort Lauderdale.